Close Menu

NEW YORK – Pacific Biosciences on Monday said that it expects to report fourth quarter revenues of around $27 million, representing a sequential quarterly increase of 41 percent but a slight decline from the $27.9 million revenues reported for Q4 2019.

The preliminary revenues surpass the consensus Wall Street estimate for revenues of $23.7 million. Despite the beat, in early Monday trade on the Nasdaq, shares of PacBio were down around 3 percent at $33.51

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Centers for Disease Control and Prevention has identified a small group of breakthrough COVID-19 cases, the Wall Street Journal reports.

The New York Times reports that the US Department of Defense is to use genetic genealogy approaches to identify the remains of unknown soldiers.

Vox and Nature discuss the importance of preparing for the next pandemic.

In Nature this week: comparison of five circulating tumor DNA assays, resequencing analysis of lettuce gives insight into its domestication, and more.